Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Virol. 29, 281-296 (1975).
MEM
3. Eagle, H., et al., myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue
Culture. J.Biol. Chem., 214, 845-847(1956).
4. Eagle
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
Essential Growth Factor for Normal and Malignant Human
Cells in Tissue Culture. J.Biol. Chem. 214, 845-847.
2. Eagle, H. (1976) Media for Animal Cell Culture. Tissue Culture Association Manual. 3
600 pM). Exhibits about 360-fold greater
selectivity for cathepsin L compared to cathepsin B
(Ki = 214 nM). Purity: single spot by TLC.
Cat. No. 219435 1 mg
Ref.: Lynas, J.F., et al. 2000. Bioorg.
IB, IF
100 ml €331
Anti-PARP-1 (197-214) Rabbit pAb 512738 Undiluted serum . Immunogen used was a synthetic peptide corresponding to amino acids
197-214 of human PARP . Recognizes the ~116 kDa full-length
II. Suitable for the
dephosphorylation of phosphotyrosine residues in substrate proteins.
20 µg 214
Protein Tyrosine
Phosphatase PRL-3,
GST-Fusion, Human,
Recombinant, E. coli
539807 The catalytic
A 1 mM
(100 µg/214 µl) solution of Staurosporine (Cat. No.569396) in DMSO is also available.
100 µg
250 µg
TX-1123 655200 [2-((3,5-di-tert-Butyl-4-hydroxyphenyl)-methylene)-4-cyclopentene-1,3-
sc
en
t
co
lo
ni
es
D
if
fe
re
nc
e
m
us
t
be
va
li
da
te
d
214 PDA Journal of Pharmaceutical Science and Technology
on June 29, 2017journal.pda.orgDownloaded
sc
en
t
co
lo
ni
es
D
if
fe
re
nc
e
m
us
t
be
va
li
da
te
d
214 PDA Journal of Pharmaceutical Science and Technology
Copyright PDA: Licensed to Merck KGaA, Darmstadt